| Identification | Back Directory | [Name]
Benzeneacetamide, α-(2,2-difluoroethyl)-4-fluoro-N-[4-[4,5,6,7-tetrahydro-5-methyl-4-oxo-3-(phenylamino)-1H-pyrrolo[3,2-c]pyridin-2-yl]-2-pyridinyl]-, (αR)- | [CAS]
2468784-55-4 | [Synonyms]
Benzeneacetamide, α-(2,2-difluoroethyl)-4-fluoro-N-[4-[4,5,6,7-tetrahydro-5-methyl-4-oxo-3-(phenylamino)-1H-pyrrolo[3,2-c]pyridin-2-yl]-2-pyridinyl]-, (αR)- | [Molecular Formula]
C29H26F3N5O2 | [MOL File]
2468784-55-4.mol | [Molecular Weight]
533.54 |
| Chemical Properties | Back Directory | [Boiling point ]
786.5±60.0 °C(Predicted) | [density ]
1.369±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
12.28±0.70(Predicted) | [color ]
Light yellow to yellow |
| Hazard Information | Back Directory | [Uses]
CSNK1-IN-1 is a CSNK1A1 inhibitor. CSNK1-IN-1 has inhibitory activity for CSNK1A1 kinase with IC50 values of 21 μM. CSNK1-IN-1 can be used for the research of proliferative disorders[1]. | [References]
[1] Volker Schulze, et al. 3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as csnk1 inhibitors. Patent. WO2020161257 A1. |
|
|